901 – 910 of 1422
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Analysis of TBC1D4 in patients with severe insulin resistance
(
- Contribution to journal › Letter
-
Mark
An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics
(
- Contribution to journal › Article
-
Mark
Differences in associations between HSD11B1 gene expression and metabolic parameters in subjects with and without impaired glucose homeostasis
(
- Contribution to journal › Article
-
Mark
The common functional polymorphism -50G>T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes.
(
- Contribution to journal › Article
-
Mark
Interpretation of genome wide association data for lipoprotein traits using systems biology approach
2010) 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD) In Diabetologia 53(Suppl. 1). p.323-323(
- Contribution to journal › Published meeting abstract
-
Mark
NordicDB: a Nordic pool and portal for genome-wide control data
(
- Contribution to journal › Article
-
Mark
The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes
(
- Contribution to journal › Article
-
Mark
A lipotoxicity model in the INS-1 832/13 beta cell line and the epigenetic alterations induced by it
2010) 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD) In Diabetologia 53(Suppl. 1). p.348-348(
- Contribution to journal › Published meeting abstract
-
Mark
Akt influences glycogen synthase in skeletal muscle through regulation of NH2-terminal phosphorylation
2010) 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD) In Diabetologia 53(Suppl. 1). p.696-696(
- Contribution to journal › Published meeting abstract
-
Mark
Increased levels of cortisol and IGF-I after treatment with pioglitazone in patients with diabetes mellitus type 2
(
- Contribution to journal › Published meeting abstract